NVCR (NVCR) Stock Price & Analysis
NVCR (NVCR) rose 0.00% to USD 17.65 as of July 25, 2026 at 03:10 UTC, according to Nexqual real-time market data.
NVCR last closed at USD 17.65; the session ranged USD 17.6–21.36 on volume of 3,874,044 shares. Market capitalization is —, with a 52-week range of USD 9.82–21.45 (NMS). Source: Nexqual, July 25, 2026 at 03:10 UTC.
Key Statistics (as of July 25, 2026 at 03:10 UTC)
| Price | USD 17.65 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 17.65 |
| Open | USD 17.65 |
| Day Range | USD 17.6 – 21.36 |
| 52-Week Range | USD 9.82 – 21.45 |
| Volume | 3,874,044 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (NVCR)
Nexqual's technical model rates NVCR "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:10 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.92 (neutral) |
| vs SMA50 | Above (USD 16.72) |
| MACD | 0.28 (positive) |
From NVCR's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GH | Guardant Health, Inc. | USD 147.33 | ▼ 2.27% |
| RGEN | Repligen Corporation | USD 131.96 | ▼ 5.8% |
| QDEL | QuidelOrtho Corporation | USD 16.05 | ▼ 3.78% |
| DXCM | DexCom, Inc. | USD 71.54 | ▲ 0.15% |
| PODD | Insulet Corporation | USD 163.26 | ▲ 2.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:10 UTC. This page is informational and not investment advice.